Normothermic Ex Vivo Pancreas Perfusion for the Preservation of Pancreas Allografts before Transplantation
July 27th, 2022
3.5K views
Normothermic ex vivo machine perfusion (NEVP) has scarcely been explored for the preservation of pancreas allografts. We present an innovative preservation technique for pancreas allografts before transplantation.
Overview
This study explores the innovative technique of Normothermic Ex Vivo Machine Perfusion (NEVP) for the preservation of pancreas allografts. The method aims to enhance the viability of pancreas transplants, which are often discarded, thereby potentially increasing the donor pool for patients with diabetes.
Key Study Components
Area of Science
- Transplantation Biology
- Organ Preservation Techniques
- Diabetes Treatment Strategies
Background
- Pancreas transplantation is a curative option for diabetes.
- Organs for transplantation are limited, necessitating improved preservation methods.
- NEVP has shown promise in preserving other organs.
- Understanding ischemia-reperfusion injury is crucial for improving transplant outcomes.
Purpose of Study
- To evaluate NEVP as a preservation method for pancreas allografts.
- To assess the potential for increasing the organ donor pool.
- To identify biomarkers related to pancreas damage during preservation.
Methods Used
- Detailed surgical retrieval of the pancreas and associated vessels.
- Application of University of Wisconsin Preservation Solution for organ flushing.
- Setup of a perfusion system to maintain organ viability.
- Monitoring of various physiological parameters during perfusion.
Main Results
- Successful implementation of NEVP for pancreas preservation.
- Improved understanding of the pancreas's response to preservation techniques.
- Identification of key parameters influencing graft viability.
- Potential for increased availability of pancreas allografts for transplantation.
Conclusions
- NEVP shows promise as a viable method for pancreas preservation.
- This technique could significantly impact the treatment of diabetes through enhanced transplant availability.
- Further research is needed to refine the method and assess long-term outcomes.
Frequently Asked Questions
What is Normothermic Ex Vivo Machine Perfusion?
It is a technique used to preserve organs, such as pancreas allografts, outside the body at normal body temperature.
Why is pancreas transplantation important?
It offers a potential cure for individuals with diabetes, especially those with severe complications.
What are the challenges in pancreas transplantation?
The main challenges include organ scarcity and the preservation of organ viability during transport.
How does NEVP improve organ preservation?
NEVP allows for better assessment and potential repair of pancreas allografts, enhancing their viability.
What are biomarkers of pancreas damage?
Biomarkers are indicators that can help assess the condition of the pancreas during preservation and after transplantation.
What is the significance of ischemia-reperfusion injury?
It refers to damage caused when blood supply returns to the tissue after a period of ischemia, which is critical to understand for improving transplant outcomes.
Executive Industry Relevance
Normothermic ex vivo pancreas perfusion (NEVP) addresses a critical bottleneck in pancreas transplantation by enabling functional assessment and preservation of marginal allografts. This approach supports expansion of the donor pool and provides a platform for mechanistic study of ischemia-reperfusion injury, directly impacting early discovery and translational research in organ preservation. NEVP's quantitative outputs and biomarker analysis inform risk-adjusted advancement decisions for transplant programs and regenerative medicine portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of ischemia-reperfusion injury mechanisms in a controlled, physiologically relevant system.
- Supports identification and validation of biomarkers indicative of pancreas viability and damage.
- Facilitates biological de-risking for organ preservation strategies and therapeutic interventions.
Screening & Assay Development
- Provides a reproducible platform for quantitative measurement of metabolic and injury markers during perfusion.
- Standardizes assessment of physiological parameters such as pH, electrolytes, and enzyme release.
- Enables readiness for compound screening aimed at organ repair or preservation enhancement.
Translational & Preclinical Research
- Aligns with disease-relevant models for diabetes and transplantation research.
- Supports continuity from mechanistic discovery to preclinical validation of preservation or repair interventions.
- Informs translational biomarker development for organ viability assessment.
Pipeline & Workflow Integration
NEVP integrates into the discovery-to-preclinical continuum by enabling hypothesis-driven testing of preservation strategies and therapeutic candidates in a physiologically relevant organ system.
- Discovery Biology: Supports mechanistic studies of injury and repair pathways in pancreas tissue.
- Screening: Delivers quantitative, reproducible outputs for comparing preservation conditions or interventions.
- Analytics: Provides real-time measurement of metabolic activity, enzyme release, and physiological stability.
- Translational Research: Bridges discovery findings to preclinical models for diabetes and transplantation.
- Enterprise Reuse: Establishes a reusable platform for organ assessment, biomarker validation, and therapeutic screening.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in organ viability and mechanistic understanding of injury.
- Operational Value: Standardizes organ assessment and enables reproducible, scalable workflows.
- Strategic Value: Improves go/no-go decisions for organ acceptance and therapeutic candidate advancement.
- Portfolio Impact: Supports risk-adjusted prioritization of preservation and repair strategies across programs.
Implementation Considerations
- Requires expertise in surgical retrieval, perfusion setup, and physiological monitoring.
- Demands specialized instrumentation for pressure, flow, and metabolic measurements.
- Necessitates cross-team standardization of perfusion protocols and analytical endpoints.
- Adaptation may be needed for different organ types or donor criteria.
- Careful handling is essential due to pancreas sensitivity and risk of edema.
Biopharma FAQs
Why does null hypothesis testing matter for NEVP biomarker validation?
Null hypothesis testing ensures that observed changes in biomarkers such as amylase, lipase, or metabolic parameters during NEVP are statistically significant and not due to random variation, supporting robust target validation for organ viability assessment.
How does independent variable isolation in perfusion setup support discovery?
Isolating variables such as perfusate composition or temperature in the NEVP system allows researchers to attribute observed physiological changes directly to specific interventions, strengthening mechanistic insights and discovery-stage confidence.
What do quantitative dependent variable measurements enable in NEVP?
Quantitative tracking of parameters like oxygen consumption, pH, and enzyme release enables objective comparison of preservation strategies and supports data-driven decisions for advancing organ repair or acceptance protocols.
Why are replication requirements critical for cross-functional NEVP studies?
Replication ensures that NEVP findings—such as stability of pressure, flow, and metabolic markers—are reproducible across teams and settings, facilitating cross-functional collaboration and enterprise-wide adoption of validated protocols.
What statistical analysis capabilities are needed before NEVP implementation?
Robust statistical tools are required to analyze physiological and biomarker data from NEVP, enabling teams to distinguish meaningful effects from background noise and to set actionable thresholds for organ viability and intervention efficacy.
Chapters in this video
0:05
Introduction
1:04
Surgical Procedure
3:31
Back Table Preparation of the Pancreatic Graft
4:22
Normothermic Ex Vivo Pancreas Perfusion
5:07
Preparation of the Perfusate and Priming of the Circuit
6:07
Pancreas Graft Perfusion
7:28
Results: Normothermic Ex Vivo Machine Perfusion for the Preservation of Pancreas Allografts
8:18
Conclusion
